Lynda Lombardi, NP
Family · Groton, CTNPI 1992128128
Payments from drug & device makers
Across 19 payments — averaging $22.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$85
- Mallinckrodt Hospital Products Inc.$60
- Novo Nordisk$38
- E.r. Squibb & Sons, L.L.C.$35
- Amgen$33
- UCB, Inc.$31
- plus $145 from 7 others
What the payments were for
- Food & beverage$36586%
- Education$6014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $85 |
| Mallinckrodt Hospital Products Inc. | 1 | $60 |
| Novo Nordisk | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Amgen(2 entities) | 2 | $33 |
| UCB, Inc. | 1 | $31 |
| Boehringer Ingelheim | 1 | $26 |
| Sunovion Pharmaceuticals Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| AstraZeneca | 1 | $15 |
How this compares
$425 in reported general payments places this provider in the 55th percentile of 1,596 family providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 21 | $1,176 |
| Escitalopram Oxalate | 20 | $289 |
| Trazodone Hcl | 15 | $277 |
| Atorvastatin Calcium | 22 | $245 |
| Clonazepam | 11 | $238 |
| CefuroximeCefuroxime Axetil | 15 | $187 |
| Ondansetron Hcl | 16 | $174 |
| Lorazepam | 15 | $169 |
| Amlodipine Besylate | 11 | $168 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $166 |
| Losartan Potassium | 14 | $159 |
| Rosuvastatin Calcium | 14 | $147 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $111 |
| Hydrochlorothiazide | 19 | $76 |
| Metformin Hcl ErMetformin Hcl | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Other family in Groton
- Elisha ChristiansonWaterbury$371K
- Kathryn TierneyNew Britain$140K
- Jennifer SilvaSouth Windsor$91K
- Carli WillardEnfield$74K
- Erin MartinMilford$70K
- Dayna GiordanoNew Haven$65K
- Diana BytyqiDerby$53K
- Farhiya AbdiSouth Windsor$30K
- Nicole SandilandsBridgeport$30K
- Ralph HirschfeldPutnam$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.